Going to extremes: the Goldilocks/Lagom principle and data distribution.
data analysis and interpretation
data distributions
statistics & research methods
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
27 11 2019
27 11 2019
Historique:
entrez:
30
11
2019
pubmed:
30
11
2019
medline:
31
10
2020
Statut:
epublish
Résumé
Numerical data in biology and medicine are commonly presented as mean or median with error or confidence limits, to the exclusion of individual values. Analysis of our own and others' data indicates that this practice risks excluding 'Goldilocks' effects in which a biological variable falls within a range between 'too much' and 'too little' with a region between where its function is 'just right'; a concept captured by the Swedish term 'Lagom'. This was confirmed by a narrative search of the literature using the PubMed database, which revealed numerous relationships of biological and clinical phenomena of the Goldilocks/Lagom form including quantitative and qualitative examples from the health and social sciences. Some possible mechanisms underlying these phenomena are considered. We conclude that retrospective analysis of existing data will most likely reveal a vast number of such distributions to the benefit of medical understanding and clinical care and that a transparent approach of presenting each value within a dataset individually should be adopted to ensure a more complete evaluation of research studies in future.
Identifiants
pubmed: 31780584
pii: bmjopen-2018-027767
doi: 10.1136/bmjopen-2018-027767
pmc: PMC6887037
doi:
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e027767Subventions
Organisme : Medical Research Council
ID : G0801057
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
PLoS Biol. 2015 Apr 22;13(4):e1002128
pubmed: 25901488
Integr Comp Biol. 2013 Oct;53(4):597-608
pubmed: 23615362
J Exp Biol. 2016 Dec 15;219(Pt 24):3832-3843
pubmed: 27852750
Diabetes Care. 2011 Jan;34 Suppl 1:S62-9
pubmed: 21193628
PLoS One. 2013 Aug 15;8(8):e67834
pubmed: 23967049
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
J Mol Endocrinol. 2002 Aug;29(1):113-23
pubmed: 12200233
Br J Pharmacol. 2017 Sep;174(17):2801-2804
pubmed: 28801996
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
Lancet. 2010 Feb 6;375(9713):481-9
pubmed: 20110121
Curr Opin Lipidol. 2006 Dec;17(6):637-43
pubmed: 17095908
Biochemistry. 2008 Jul 15;47(28):7465-76
pubmed: 18558711
IUBMB Life. 2005 Jul;57(7):483-90
pubmed: 16081369
Dose Response. 2013 Oct 07;12(2):259-76
pubmed: 24910584
Mol Reprod Dev. 2016 Sep;83(9):748-754
pubmed: 27465801
Lancet Diabetes Endocrinol. 2018 Jun;6(6):476-486
pubmed: 29674135
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
J Biol Eng. 2013 Feb 20;7(1):6
pubmed: 23421993
Environ Health Perspect. 2003 Jun;111(8):994-1006
pubmed: 12826473
J Med Food. 1999;2(3-4):139-42
pubmed: 19281365
J Clin Endocrinol Metab. 2014 Mar;99(3):800-7
pubmed: 24423327